Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.

导出 OA

翻译打印收藏纠错

作者： Livnat,Brill ^[1] ; Catarina,Raposo ^[2] ; Ariel,Rechtman ^[1] ; Omri,Zveik ^[1] ; Netta,Levin ^[1] ; Esther,Oiknine-Djian ^[3] ; Dana G,Wolf ^[4] ; Adi,Vaknin-Dembinsky ^[3]

作者单位： Department of Neurology, Laboratory of Neuroimmunology, and Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. ^[1] F. Hoffmann-La Roche, Basel, Switzerland. ^[2] Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel. ^[3] Lautenberg Center for General and Tumor Immunology, Hebrew University Faculty of Medicine, Jerusalem, Israel. ^[4]

主题词抗体, 病毒(Antibodies, Viral);人类(Humans);免疫(Immunity);多发性硬化(Multiple Sclerosis);疫苗, 合成(Vaccines, Synthetic)

DOI 10.1002/ana.26343

PMID 35243687

发布时间 2023-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交